Updates
COVID-19 Vaccination and Addiction Treatment
The dissemination of effective vaccines against the COVID-19 virus is a key strategy towards controlling the COVID-19 pandemic and people with substance use disorders are at higher risk for COVID-19 infections and serious sequalae than the general population. The ASAM...
NIH-Funded Study Tests “One-Stop” Mobile Clinics to Deliver Substance Use, HIV Care
A clinical trial is underway in five U.S. cities to determine whether delivering integrated health services through mobile clinics can improve HIV and substance use outcomes among people with opioid use disorder who inject drugs....
Inflammatory Processes are Altered in the Brains of People with Opioid Use Disorder
Prevalence rates of opioid use disorder (OUD) have increased dramatically, accompanied by a surge of overdose deaths–nearly 50,000 in the U.S. in 2019. While opioid dependence has been extensively studied in preclinical models, an understanding of the biological...
America Has a Drinking Problem
Few things are more American than drinking heavily. But worrying about how heavily other Americans are drinking is one of them. The Mayflower landed at Plymouth Rock because, the crew feared, the Pilgrims were going through the beer too quickly. Read more:...
Researchers Test Prediction Model for Overdose Deaths
The number of Americans who die each year from drug overdoses has steadily risen over the past two decades, from less than 20,000 in 1999 to more than 80,000 in 2020. By studying patterns of these drug-related fatalities, researchers at University of California San...
75% of NC Overdose Deaths Involve Multiple Drugs
The street drug market has become increasingly polluted by additives in recent years. Fentanyl is the number one among those, as it is commonly added to heroin and now other substances as well. Fentanyl and its close relative, carfentanil, are synthetic opioids...
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Save the Date! More information will be posted on our website as it is available.
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Learn more about our conferences and educational opportunities
Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.